FDA lifts hold on Pluristem s stem cell trial after tweaking protocolFierceBiotechIsrael s Pluristem Therapeutics ($PSTI) says the FDA has given the company a green light to push ahead on a mid-stage study of one of its stem cell therapies after the agency had finished its review of one patient s severe allergic reaction and tweaked FDA lifts [ ]
http://blog.zandcell.com/fda-lifts-hold-on-pluristems-stem-cell-trial-after-tweaking-protocol-fiercebiotech/?utm_source=rss&utm_medium=rss&utm_campaign=fda-lifts-hold-on-pluristems-stem-cell-trial-after-tweaking-protocol-fiercebiotech
Inga kommentarer:
Skicka en kommentar